Part of our Complete Guide to Research Peptides.

GHK-Cu Research Overview: What the Literature Says

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper) first identified in human plasma in 1973. It has been studied extensively in dermatological and tissue-repair research contexts, making it one of the longer-documented compounds in the research peptide space.

GHK-Cu research peptide vial, HPLC verified purity

Background on GHK-Cu Research

GHK was first isolated from human plasma by researcher Loren Pickart, who observed that plasma from younger donors had measurable effects on liver cell protein expression that plasma from older donors did not. The active component was identified as this tripeptide, which naturally complexes with copper ions to form GHK-Cu. Plasma concentrations of GHK-Cu are known to decline with age, which is part of what has driven sustained research interest in the compound.

What the Research Covers

Laboratory studies on GHK-Cu span several overlapping areas:

  • Skin repair pathways — extensively studied in laboratory models for its role in wound healing processes, including studies in rabbit, rat, mouse, and pig models.
  • Collagen production — research has examined its effects on fibroblast activity, collagen and elastin synthesis, and glycosaminoglycan production in cell culture models, with measurable effects reported at concentrations as low as 1–10 nanomolar.
  • Antioxidant and anti-inflammatory signaling — studies have explored its interaction with oxidative stress pathways and inflammatory cytokine activity relevant to tissue aging research.
  • Gene expression modulation — research has indicated GHK-Cu is capable of influencing the expression of a large number of genes, a finding that has driven interest in its broader role in cellular remodeling processes.

GHK-Cu also modulates the activity of matrix metalloproteinases and their natural inhibitors (TIMP-1 and TIMP-2), which researchers consider a key regulatory mechanism in wound healing and tissue remodeling models. For a detailed review of these mechanisms, see: GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (PubMed Central).

As with other research peptides, the majority of published work on GHK-Cu has been conducted in animal models and cell culture systems. Researchers should consult primary literature directly when designing studies involving this compound.

Purity Considerations

Because GHK-Cu is a copper-complexed peptide, verifying both peptide purity and correct copper binding via HPLC is important for research consistency. Our GHK-Cu Peptide, 100mg is supplied with third-party HPLC verification for every batch.

Handling and Reconstitution

GHK-Cu is supplied in lyophilized form and requires reconstitution with an appropriate diluent before use in a research application. See our Reconstitution Guide for general laboratory technique.

Frequently Referenced Study Areas

Beyond wound healing, GHK-Cu appears in a growing body of literature examining broader applications of copper peptide research. Studies have explored its effects in models relevant to chronic wound conditions, including diabetic and ischemic wound models in rodents, where researchers have observed effects on inflammatory cytokine levels and antioxidant enzyme activity. Comparative studies have also examined GHK-Cu alongside other tissue-repair compounds to better characterize its specific mechanism relative to broader wound-healing pathways.

Researchers frequently reference GHK-Cu’s stability profile when designing studies, since its copper-binding structure affects how it behaves in solution compared to non-metal-complexed peptides. This has made it a useful reference compound in studies examining metal-peptide complex stability more broadly, an area of growing interest as more copper- and other metal-bound peptides enter the research literature.

This page is provided for general research and educational reference only. It is not a substitute for reviewing primary published literature, and it is not intended to suggest any use in humans or animals. All products sold by PNW Peptides LLC are supplied strictly for laboratory research use (RUO) and are not for human or veterinary consumption. See our RUO Disclaimer.